Long-term follow-up shows need for new chemotherapy strategies for rectal cancer
Thursday, January 23, 2014 - 12:24
in Health & Medicine
Long-term results of EORTC trial 22921 with 10.4 years median follow-up show that 5-FU-based adjuvant chemotherapy after preoperative (chemo)-radiotherapy for patients with cT3-resectable T4 M0 rectal cancer does not improve survival or disease-free survival.